---
$id: https://graph.org.ai/products/commodity/51111637
$type: Product
source: UNSPSC
code: "51111637"
title: "Evandamine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Evandamine

**UNSPSC Code**: 51111637
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a lipooxygenase inhibitor with the molecular formula C11H16N4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZG2L2878MD, chemically known as (- )-2-(3-amino-5-methyl-2-pyrazolin-1-yl)-4,5,6,7-tetrahydrobenzothiazole. but generally known as evandamine, which bears US NIH Compound Identifier 3038554. European Medicines Agency schedules Evandamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07353MIG. The term EVANDAMINE is an International Non-Proprietary Name. EVANDAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule evandamine under HS 29341000 and SITC 51579. As of Q4 2014, EVANDAMINE remains the US FDA Preferred Term for this commodity. Evandamine bears US NLM identifiers UMLS ID C1880595 and NCI Concept Code C65604. SMILES: CC1CC(=NN1C2=NC3=C(S2)CCCC3)N.

